Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05791643 · ClinicalTrials.gov registry record · NA
Promoting Safety Plan and Coping Strategy Use Among Adults With Suicidal Thoughts
A NA study of Suicide, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 103
- Enrollment target
- 2
- Study locations
NCT05791643: Completed NA study of Suicide, sponsored by Massachusetts General Hospital.
NCT05791643 is a NA study of Suicide that has completed, run by Massachusetts General Hospital. The registered enrollment target is 103 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05791643, a NA study of Suicide, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to learn about a new, real-time, smartphone-based intervention aimed to decrease risk for suicide in adults who have been hospitalized for suicidal thoughts or behaviors. The main questions the investigators aim to answer are: * Is a real-time, smartphone-based intervention that promotes the use of safety plans and other coping strategies for suicidal thoughts feasible and acceptable? * Does the real-time intervention result in increased use of safety plans and other coping strategies, and reduce suicidal thoughts? Participants will: * Answer questions about current suicidal thoughts on their smartphone up to 6 times each day while they are in the hospital and during the 4 weeks after they leave the hospital * When they report elevated suicidal thoughts on a smartphone survey, be randomly assigned to receive or not receive automated, interactive reminders to use content from their personalized safety plan or general coping strategies * Answer brief follow-up questions on their smartphone within a couple hours of receiving or not receiving automated reminders * Give feedback on their experience with the real-time intervention
Conditions Studied
Interventions
- BEHAVIORAL Personalized internal and external coping strategies
- BEHAVIORAL Personalized internal coping strategies
- BEHAVIORAL Personalized external coping strategies
- BEHAVIORAL General internal and external coping strategies
- BEHAVIORAL General internal coping strategies
Study Locations (2)
Massachusetts
- McLean Hospital - Belmont
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2024-09-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05791643
The ClinicalTrials.gov registry entry for NCT05791643 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 5 interventions - of which Personalized internal and external coping strategies is the first listed.
NCT05791643 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05791643 about?
NCT05791643 is a clinical study titled "Promoting Safety Plan and Coping Strategy Use Among Adults With Suicidal Thoughts". The goal of this study is to learn about a new, real-time, smartphone-based intervention aimed to decrease risk for suicide in adults who have been hospitalized for suicidal thoughts or behaviors. The main questions the investigators aim to answer are: * Is a real-time, smartphone-based interventio...
What is the current status of trial NCT05791643?
This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2023-07-05. Estimated completion is 2024-09-03.
What conditions does trial NCT05791643 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT05791643?
The interventions under investigation include: Personalized internal and external coping strategies (BEHAVIORAL), Personalized internal coping strategies (BEHAVIORAL), Personalized external coping strategies (BEHAVIORAL), General internal and external coping strategies (BEHAVIORAL), General internal coping strategies (BEHAVIORAL).
Who is sponsoring clinical trial NCT05791643?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05791643 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.